TY  - JOUR
AU  - Suay-Corredera, Carmen
AU  - Pricolo, Maria Rosaria
AU  - Velázquez-Carreras, Diana
AU  - Pathak, Divya
AU  - Nandwani, Neha
AU  - Pimenta-Lopes, Carolina
AU  - Sánchez-Ortiz, David
AU  - Urrutia-Irazabal, Iñigo
AU  - Vilches, Silvia
AU  - Dominguez, Fernando
AU  - Frisso, Giulia
AU  - Monserrat, Lorenzo
AU  - García-Pavía, Pablo
AU  - de Sancho, David
AU  - Spudich, James A
AU  - Ruppel, Kathleen M
AU  - Herrero-Galán, Elías
AU  - Alegre-Cebollada, Jorge
PY  - 2021
DO  - 10.1021/acsnano.1c02242
UR  - http://hdl.handle.net/20.500.12105/15168
AB  - Hypertrophic cardiomyopathy (HCM) is a disease of the myocardium caused by mutations in sarcomeric proteins with mechanical roles, such as the molecular motor myosin. Around half of the HCM-causing genetic variants target contraction modulator cardiac...
LA  - eng
PB  - American Chemical Society (ACS)
KW  - Cardiomyopathy, Hypertrophic
KW  - Carrier Proteins
KW  - Humans
KW  - Mutation
KW  - Phenotype
KW  - Sarcomeres
TI  - Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.
TY  - journal article
ER  -